ClinicalTrials.gov
ClinicalTrials.gov Menu

Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy (CONSIGN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01538680
Recruitment Status : No longer available
First Posted : February 24, 2012
Last Update Posted : March 26, 2018
Sponsor:
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : No longer available
  Primary Completion Date : No date given
  Study Completion Date : No date given